Industry › BioTech
Press Releases
Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
Eisai
Jan 12, 2021 11:37 HKT/SGT
APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Apollomics, Inc.
Jan 07, 2021 20:10 HKT/SGT
AIM ImmunoTech宣布其藥物Ampligen的ME/CFS臨床試驗已開始接受COVID-19長期患者的註冊
AIM ImmunoTech Inc
Dec 24, 2020 21:00 HKT/SGT
AIM ImmunoTech Announces that the ME/CFS Clinical Trial of its Drug Ampligen is Open for Enrollment to COVID-19 'Long Haulers'
AIM ImmunoTech Inc
Dec 24, 2020 21:00 HKT/SGT
AIM ImmunoTech宣布其药物Ampligen的ME/CFS临床试验已开始接受COVID-19长期患者的注册
AIM ImmunoTech Inc
Dec 24, 2020 21:00 HKT/SGT
Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan
Eisai
Dec 18, 2020 12:09 HKT/SGT
华领医药成功完成III期注册临床研究 公布多扎格列艾汀与二甲双胍联合用药临床试验DAWN研究（HMM0302）的52周结果
Hua Medicine
Dec 18, 2020 09:17 HKT/SGT
華領醫藥成功完成III期註冊臨床研究 公佈多扎格列艾汀與二甲雙胍聯合用藥臨床試驗DAWN研究（HMM0302）的52週結果
Hua Medicine
Dec 18, 2020 09:16 HKT/SGT
